A citation-based method for searching scientific literature

Mirna B Podoll, Emily S Reisenbichler, Lania Roland, Andrew Bruner, Sarah Mizuguchi, Mary Ann G Sanders. Arch Pathol Lab Med 2018
Times Cited: 14







List of co-cited articles
100 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
54
57

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
185
57

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
196
50

Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Lars J Grimm, Marc D Ryser, Ann H Partridge, Alastair M Thompson, Jeremy S Thomas, Jelle Wesseling, E Shelley Hwang. Ann Surg Oncol 2017
48
50

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
225
42

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019
98
42

Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ: Precautions for Active Surveillance.
Carlos Chavez de Paz Villanueva, Valentina Bonev, Maheswari Senthil, Naveenraj Solomon, Mark E Reeves, Carlos A Garberoglio, Jukes P Namm, Sharon S Lum. JAMA Surg 2017
16
35

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
325
35

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
77
28

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
444
28

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
323
28

Is DCIS breast cancer, and how do I treat it?
N Bijker, M Donker, J Wesseling, G J den Heeten, E J Th Rutgers. Curr Treat Options Oncol 2013
31
28

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
211
28

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park,[...]. Breast 2012
43
28

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
318
21

Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: Critical review.
M Toss, I Miligy, A M Thompson, H Khout, A R Green, I O Ellis, E A Rakha. Breast 2017
20
21

Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Mieke Van Bockstal, Marcella Baldewijns, Cécile Colpaert, Hélène Dano, Giuseppe Floris, Christine Galant, Kathleen Lambein, Dieter Peeters, Sofie Van Renterghem, Anne-Sophie Van Rompuy,[...]. Histopathology 2018
19
21

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
138
21

Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS).
S Soumian, E T Verghese, M Booth, N Sharma, S Chaudhri, S Bradley, S Umranikar, R A Millican-Slater, A M Hanby, A Francis. Eur J Surg Oncol 2013
33
21

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
188
21

Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Anthony J Maxwell, Karen Clements, Bridget Hilton, David J Dodwell, Andrew Evans, Olive Kearins, Sarah E Pinder, Jeremy Thomas, Matthew G Wallis, Alastair M Thompson. Eur J Surg Oncol 2018
40
21

Not All Ductal Carcinomas In Situ Are Created IDLE (Indolent Lesions of Epithelial Origin).
Melissa Alexander, Jessica Beyda, Anupma Nayak, Shabnam Jaffer. Arch Pathol Lab Med 2019
5
60

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
202
21

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
173
21


RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
232
21

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
388
21


Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
251
21

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
35
21

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Amit Goyal, Anthony Douglas-Jones, Ian Monypenny, Helen Sweetland, Guy Stevens, Robert E Mansel. Breast Cancer Res Treat 2006
97
21

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
214
21

Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
Marc D Ryser, Donald L Weaver, Fengmin Zhao, Mathias Worni, Lars J Grimm, Roman Gulati, Ruth Etzioni, Terry Hyslop, Sandra J Lee, E Shelley Hwang. J Natl Cancer Inst 2019
34
21


Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
14

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Mary F Dillon, Enda W McDermott, Cecily M Quinn, Ann O'Doherty, Niall O'Higgins, Arnold D K Hill. J Surg Oncol 2006
73
14

The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ.
A Francis, L Fallowfield, D Rea. Clin Oncol (R Coll Radiol) 2015
52
14


Surgery versus monitoring and endocrine therapy for low-risk DCIS: The COMET Trial.
Linda M Youngwirth, Judy C Boughey, E Shelley Hwang. Bull Am Coll Surg 2017
34
14

Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ.
Michael S Toss, Islam M Miligy, Kylie L Gorringe, L McCaffrey, Abdulbaqi AlKawaz, Asima Abidi, Ian O Ellis, Andrew R Green, Emad A Rakha. Mod Pathol 2019
9
22

Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
N Sneige, M D Lagios, R Schwarting, W Colburn, E Atkinson, D Weber, A Sahin, B Kemp, A Hoque, S Risin,[...]. Hum Pathol 1999
50
14

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
Alastair M Thompson, Karen Clements, Shan Cheung, Sarah E Pinder, Gill Lawrence, Elinor Sawyer, Olive Kearins, Graham R Ball, Ian Tomlinson, Andrew Hanby,[...]. Eur J Cancer 2018
33
14

Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
Carlos Martínez-Pérez, Arran K Turnbull, Gregory E Ekatah, Laura M Arthur, Andrew H Sims, Jeremy S Thomas, J Michael Dixon. Cancer Treat Rev 2017
23
14


Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
Fredrik Wärnberg, Hans Garmo, Stefan Emdin, Veronica Hedberg, Linda Adwall, Kerstin Sandelin, Anita Ringberg, Per Karlsson, Lars-Gunnar Arnesson, Harald Anderson,[...]. J Clin Oncol 2014
117
14

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study.
Lindy L Visser, Lotte E Elshof, Michael Schaapveld, Koen van de Vijver, Emma J Groen, Mathilde M Almekinders, Carolien Bierman, Flora E van Leeuwen, Emiel J Rutgers, Marjanka K Schmidt,[...]. Clin Cancer Res 2018
19
14


Patient Selection for Ductal Carcinoma In Situ Observation Trials: Are the Lesions Truly Low Risk?
Gitanjali V Patel, Eduardo Pascual Van Sant, Bret Taback, Richard Ha. AJR Am J Roentgenol 2018
10
20

The diagnostic challenge of low-grade ductal carcinoma in situ.
Tracy Onega, Donald L Weaver, Paul D Frederick, Kimberly H Allison, Anna N A Tosteson, Patricia A Carney, Berta M Geller, Gary M Longton, Heidi D Nelson, Natalia V Oster,[...]. Eur J Cancer 2017
22
14

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
G Pruneri, M Lazzeroni, V Bagnardi, G B Tiburzio, N Rotmensz, A DeCensi, A Guerrieri-Gonzaga, A Vingiani, G Curigliano, S Zurrida,[...]. Ann Oncol 2017
52
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.